Quick Answer
Instil Bio, Inc. reported Total Assets of $203.52 million for fiscal year 2025.
Instil Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $203.52M | -22.8% |
| 2024 | $263.57M | -19.1% |
| 2023 | $325.63M | -32.5% |
| 2022 | $482.13M | -21.0% |
| 2021 | $609.98M | +91.2% |
| 2020 | $319.01M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $211.77M | -22.3% | -8.3% |
| June 30, 2025 | $230.99M | -21.5% | -2.7% |
| March 31, 2025 | $237.45M | -22.5% | -9.9% |
| December 31, 2024 | $263.57M | -19.1% | -3.3% |
| September 30, 2024 | $272.56M | -19.9% | -7.4% |
| June 30, 2024 | $294.32M | -27.9% | -3.9% |
| March 31, 2024 | $306.30M | -28.3% | -5.9% |
| December 31, 2023 | $325.63M | -32.5% | -4.3% |
- Instil Bio, Inc. showed a decrease of -22.8% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Instil Bio, Inc.’s total assets has declined by 36.2% (from $319.01 million to $203.52 million).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: